Primary Lymphoma of Bone

The terms "-Hodgkin's lymphoma" and "-Hodgkin lymphoma" are used interchangeably on this site

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid tissue (MALT)). It is hard to believe but the bones are an important part of the lymphatic process: the "B" in white b-cell is for cell maturation in the bone marrow.

Lymphomas (Nonhodgkin's mostly, rarely Hodgkin's lymphoma) can start in the bone. These lymphomas are all quite rare, 1-3% of bone tumors. The lymphoma can be an aggressive one or an indolent form. These are not to be confused with lymphomas that have spread to the bone from other areas.

Lymphoma of bone strikes more men than women (4:3 ratio). They can occur at all ages but is rare in pediatric (childhood) patients. 20% of cases are adults in their 60s.

Symptoms

The main symptom is localized pain which has been present for months if not years. The area of the primary tumor may be tender or swell. Fever and weight loss do not occur.

Treatment

If the tumor is localized, chemotherapy and/or radiotherapy may be given. The oncologist may elect to surgically remove the affected bone. Radiation may be given if local lymph nodes are involved where as chemotherapy may be called for for disease that has spread. Exact treatment will be determined by your doctor based on what testing finds.

Clinical Trial Locator

Follow this link to identify a conveniently located cancer treatment center and begin the process of enrollment.

Non-Hodgkin Lymphoma Information Pages:

Hodgkin's Lymphoma Page

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap